VeritasInSilico Inc. Announces Completion of Shinkawasaki Laboratory Relocation and Opening of Kawasaki Laboratory
Drug discovery venture Veritas In Silico has relocated its Shinkawasaki laboratory and opened a new Kawasaki laboratory. The objective is to strengthen its R&D system to accelerate mRNA-targeted drug discovery, showing ambition for business expansion.
📋 Article Processing Timeline
- 📰 Published: April 22, 2026 at 17:08
- 🔍 Collected: April 22, 2026 at 17:32 (23 min after Published)
- 🤖 AI Analyzed: April 22, 2026 at 21:00 (3h 28m after Collected)
Veritas In Silico possesses the ibVIS® platform, which enables the creation of small molecule and nucleic acid drugs targeting the partial structures of mRNA, and conducts mRNA-targeted drug discovery research in partnership with pharmaceutical companies.